Clinical Trial Update: Study to Assess the Efficacy and Safety of MEDI3506 in Adults With Uncontrolled Moderate-to-severe Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial assessing MEDI3506 in adults with uncontrolled moderate-to-severe asthma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• MEDI3506

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2024-01-30